COVID-19 continues to stimulate sales of cough and cold remedies in Q1 and Q2 of 2021, as consumers remain cautious and begin treatment as soon as the first symptoms occur. The highest demand is in cough remedies, due to the higher incidences of pneumonia due to COVID-19.
Antihistamines/allergy remedies (systemic) saw an increase in demand in the spring of 2021, as consumers spent more time outdoors. While the higher prevalence of combination products which have antihistamine properties (as noted in analgesics) has led to it being easier for consumers to purchase a product with multiple uses, which could treat both a cold and an allergy equally well, seasonal selling recommenced, and the category is expected to continue to see constant growth from 2022 onwards (dependent on associated COVID-19 factors).
Domestic player Lekpharm SOOO leads cough, cold and allergy (hay fever) remedies in 2021 with its Arpetol brand, along with Grippomix which holds smaller brand shares. This is a highly competitive category, with a number of new product developments.
As already noted, Belarusians are typically health conscious and mainly prefer to follow a balanced diet with immune-boosting natural ingredients. For example, using garlic, honey and lemon, which are known for their anti-inflammatory effects, to treat the symptoms of a cold.
Due to the high levels of competition and the fact that global players use television and social media advertising to promote their products, it is important for domestic players to also embrace the advertising channel in order to enhance their sales. Whilst domestic players typically do not have the budgets to enable them to advertise to the same level (for example on television), it is important for local companies to at least enhance brand awareness through social media and other multimedia channels as they are able.
As seen in analgesics, domestic players look set to maintain their competitive advantage over global players over the forecast period. This is evidenced by the strongest and most active new product developments coming from domestic companies and global giants such as GSK Consumer Healthcare (GlaxoSmithKline Plc) not re-registering some of its products for sale in Belarus.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Belarus with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Belarus, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Cough, Cold and Allergy (Hay Fever) Remedies
This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.
See All of Our DefinitionsThis report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!